Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.

[1]  Kwangmeyung Kim,et al.  Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Kwangmeyung Kim,et al.  Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[3]  T. Park,et al.  Stabilized calcium phosphate nano-aggregates using a dopa-chitosan conjugate for gene delivery. , 2013, International journal of pharmaceutics.

[4]  N. Nishiyama,et al.  Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[5]  M. Mummert,et al.  Hyaluronan Endocytosis: Mechanisms of Uptake and Biological Functions , 2012 .

[6]  Leaf Huang,et al.  Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  In‐San Kim,et al.  Mineralized hyaluronic acid nanoparticles as a robust drug carrier , 2011 .

[8]  Qiao-ling Hu,et al.  A facile approach to construct hyaluronic acid shielding polyplexes with improved stability and reduced cytotoxicity. , 2011, Colloids and surfaces. B, Biointerfaces.

[9]  P. Dittrich,et al.  Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[10]  M. de la Fuente,et al.  Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells , 2011, Molecular vision.

[11]  Haeshin Lee,et al.  Mussel‐Inspired Polydopamine Coating as a Universal Route to Hydroxyapatite Crystallization , 2010 .

[12]  Min-young Lee,et al.  Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. , 2010, Biomaterials.

[13]  D. Curiel,et al.  Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor , 2010, Journal of ovarian research.

[14]  Yu-cheng Tseng,et al.  Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[15]  A. Hoffman,et al.  Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Yuichi Yamasaki,et al.  PEGylated Calcium Phosphate Nanocomposites as Smart Environment‐Sensitive Carriers for siRNA Delivery , 2009 .

[17]  G. Stucky,et al.  Metals and the integrity of a biological coating: the cuticle of mussel byssus. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[18]  T. Park,et al.  Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. , 2008, Biopolymers.

[19]  F. Szoka,et al.  Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. , 2008, Molecular pharmaceutics.

[20]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer , 2008, Clinical Cancer Research.

[21]  Bruce P. Lee,et al.  A reversible wet/dry adhesive inspired by mussels and geckos , 2007, Nature.

[22]  Yu-Kyoung Oh,et al.  Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Sung Wan Kim,et al.  Current status of polymeric gene delivery systems. , 2006, Advanced drug delivery reviews.

[24]  K. Kataoka,et al.  Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Kazunori Kataoka,et al.  Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[26]  William M. Chirdon,et al.  Adsorption of catechol and comparative solutes on hydroxyapatite. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[27]  Mark von Zastrow,et al.  Signal transduction and endocytosis: close encounters of many kinds , 2002, Nature Reviews Molecular Cell Biology.

[28]  M. Okazaki,et al.  Affinity binding phenomena of DNA onto apatite crystals. , 2001, Biomaterials.

[29]  F. Szoka,et al.  Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. , 2001, Cancer research.

[30]  E. Turley,et al.  HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.

[31]  W. Knudson,et al.  Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. , 1993, Journal of cell science.

[32]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[33]  J. Leroux,et al.  siRNA Transfection with Calcium Phosphate Nanoparticles Stabilized with PEGylated Chelators , 2013, Advanced healthcare materials.

[34]  Matthias Epple,et al.  Application of calcium phosphate nanoparticles in biomedicine , 2010 .

[35]  F. Szoka,et al.  Interactions of hyaluronan-targeted liposomes with cultured cells: modeling of binding and endocytosis. , 2004, Methods in enzymology.

[36]  T. Laurent.  Biochemistry of hyaluronan. , 1987, Acta oto-laryngologica. Supplementum.